Hunter DeKoninck

Comprehensive DEA regulatory counseling

Hunter DeKoninck primarily focuses on matters related to compliance with the Controlled Substances Act (CSA) and with the Drug Enforcement Administration’s (DEA) implementing regulations. Hunter counsels manufacturers, distributors, dispensers and practitioners on all matters relating to the distributing, storing, dispensing, prescribing and record-keeping of controlled substances and, specifically for manufacturers and distributors, he focuses on advising regarding anti-diversion practices and suspicious order monitoring. Hunter also:

• Counsels pharmacies and other practitioners on their policies and procedures for the handling of controlled substances.
• Guides clients through investigations by the DEA (and other regulatory bodies) associated with diversion, record-keeping violations and other regulatory matters.
• Represents wholesale drug distributors in national opioid multidistrict litigation (MDL).

• Advises large wholesale drug distributors on DEA compliance, suspicious order monitoring (SOM) policies and procedures, customer risk assessment regarding historical purchasing patterns and other DEA-related matters.
• Defends prescribers and dispensers investigated by the DEA, state attorneys general and boards of pharmacy.